By Paul Dinsdale2000-11-30T00:00:00
Senior influenza experts have joined a growing backlash against the anti-flu drug Relenza which they fear could have potentially serious financial effects on the NHS and they claim is of unproven clinical effectiveness.
With a HSJ subscription you’ll unlock:
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud